Stock listing

STVN Stock Price, News, Filings & Events — Stevanato Group S.p.a.

Selected listing: STVN · NYSE · USD · US

This page tracks Stevanato Group S.p.a.'s STVN:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following STVN:NYSE. STVN:NYSE is the stock-level entry point for investors researching Stevanato Group S.p.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Stevanato Group S.p.A. is a public company traded under the ticker STVN in the American market. With a market capitalization of approximately $5.23 billion, the company specializes in providing advanced drug delivery systems and integrated solutions for the pharmaceutical industry. Stevanato Group focuses on innovation and quality to meet the needs of its clients in the healthcare sector.

STVN:NYSEUSDUSUpdated September 18, 2026
Stevanato Group S.p.a. logo
Ticker
STVN:NYSE
Asset type
Stock
Market cap
$5.92B
Sector
Health Technology
Industry
Medical Specialties
Exchange
NYSE
Currency
USD

Stevanato Group S.p.a. STVN:NYSE stock context

This page tracks Stevanato Group S.p.a.'s STVN:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following STVN:NYSE. STVN:NYSE is the stock-level entry point for investors researching Stevanato Group S.p.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Stevanato Group S.p.A. is a public company traded under the ticker STVN in the American market. With a market capitalization of approximately $5.23 billion, the company specializes in providing advanced drug delivery systems and integrated solutions for the pharmaceutical industry. Stevanato Group focuses on innovation and quality to meet the needs of its clients in the healthcare sector.

Latest news from Stevanato Group S.p.a.

All Stevanato Group S.p.a. news →

Stevanato Group S.p.a. earnings calls

Research Stevanato Group S.p.a.

Alternate listings